Response to Comments: Transurethral Waterjet Ablation of the Prostate

This document is a response to comments on the proposed Transurethral Waterjet Ablation of the Prostate policy (JE-DL38705) following a 45-day comment period. It does not itself provide clinical coverage criteria, indications, limitations, documentation requirements, or frequency limits — refer to the underlying proposed policy and final MAC determinations for actionable coverage rules.